» Articles » PMID: 28589318

Matricellular Proteins in Cancer: a Focus on Secreted Frizzled-related Proteins

Overview
Date 2017 Jun 8
PMID 28589318
Citations 10
Authors
Affiliations
Soon will be listed here.
Abstract

Tumours are complex entities, wherein cancer cells interact with myriad soluble, insoluble and cell associated factors. These microenvironmental mediators regulate tumour growth, progression and metastasis, and are produced by cancer cells and by stromal components such as fibroblast, adipocytes and immune cells. Through their ability to bind to extracellular matrix proteins, cell surface receptors and growth factors, matricellular proteins enable a dynamic reciprocity between cancer cells and their microenvironment. Hence, matricellular proteins play a critical role in tumour progression by regulating where and when cancer cells are exposed to key growth factors and regulatory proteins. Recent studies suggest that, in addition to altering Wingless (Wnt) signalling, certain members of the Secreted Frizzled Related Protein (sFRP) family are matricellular in nature. In this review, we outline the importance of matricellular proteins in cancer, and discuss how sFRPs may function to both inhibit and promote cancer progression in a context-dependent manner. By considering the matricellular functionality of sFRPs, we may better understand their apparently paradoxical roles in cancers.

Citing Articles

Deregulated circRNAs in Epithelial Ovarian Cancer With Activity in Preclinical Models: Identification of Targets and New Modalities for Therapeutic Intervention.

Weidle U, Birzele F Cancer Genomics Proteomics. 2024; 21(3):213-237.

PMID: 38670587 PMC: 11059596. DOI: 10.21873/cgp.20442.


Concentration of Secreted Frizzled-Related Proteins (SFRPs) in Non-Small Cell Lung Carcinoma Subtypes-A Preliminary Study.

Gazdzicka J, Swietek A, Hudy D, Dabrowska N, Golabek K, Rydel M Curr Oncol. 2023; 30(11):9968-9980.

PMID: 37999144 PMC: 10670352. DOI: 10.3390/curroncol30110724.


Matrix Metalloproteinases Shape the Tumor Microenvironment in Cancer Progression.

Niland S, Riscanevo A, Eble J Int J Mol Sci. 2022; 23(1).

PMID: 35008569 PMC: 8745566. DOI: 10.3390/ijms23010146.


Fibrotic Phenotype of Peritumour Mesenteric Adipose Tissue in Human Colon Cancer: A Potential Hallmark of Metastatic Properties.

Tabuso M, Adya R, Stark R, Gopalakrishnan K, Tsang Y, James S Int J Mol Sci. 2021; 22(5).

PMID: 33670920 PMC: 7957668. DOI: 10.3390/ijms22052430.


EZH2 regulates sFRP4 expression without affecting the methylation of sFRP4 promoter DNA in colorectal cancer cell lines.

Liu Y, Yu J, Xie Y, Li M, Wang F, Zhang J Exp Ther Med. 2020; 20(5):33.

PMID: 32952624 PMC: 7480130. DOI: 10.3892/etm.2020.9160.


References
1.
Egeblad M, Nakasone E, Werb Z . Tumors as organs: complex tissues that interface with the entire organism. Dev Cell. 2010; 18(6):884-901. PMC: 2905377. DOI: 10.1016/j.devcel.2010.05.012. View

2.
Liu C, Li N, Lu H, Wang Z, Chen C, Wu L . Circulating promoter methylation status in gastric adenocarcinoma and esophageal square cell carcinoma. Biomed Rep. 2014; 3(1):123-127. PMC: 4251162. DOI: 10.3892/br.2014.388. View

3.
Sun Y, Zhu D, Chen F, Qian M, Wei H, Chen W . SFRP2 augments WNT16B signaling to promote therapeutic resistance in the damaged tumor microenvironment. Oncogene. 2016; 35(33):4321-34. PMC: 4994019. DOI: 10.1038/onc.2015.494. View

4.
Dann C, Hsieh J, Rattner A, Sharma D, Nathans J, LEAHY D . Insights into Wnt binding and signalling from the structures of two Frizzled cysteine-rich domains. Nature. 2001; 412(6842):86-90. DOI: 10.1038/35083601. View

5.
Zeisberg E, Potenta S, Xie L, Zeisberg M, Kalluri R . Discovery of endothelial to mesenchymal transition as a source for carcinoma-associated fibroblasts. Cancer Res. 2007; 67(21):10123-8. DOI: 10.1158/0008-5472.CAN-07-3127. View